IKKA (Ab 23) Antilichaam

Acts as part of the IKK complex in the conventional pathway of NF-κ -B activation and phosphorylates inhibitors of NF-κ -B thus leading to the dissociation of the inhibitor/NF-κ -B complex and ultimately the degradation of the inhibitor. As part of the non-canonical pathway of NF-κ -B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-κ -B RelB-p52 complexes. Also phosphorylates NCOA3. Phosphorylates 'Ser-10' of histone H3 at NF-κ -B-regulated promoters during inflammatory responses triggered by cytokines.

1147

O15111

NP_001269.3

Human, Mouse, Rat

IKK a (Ab-23) antibody was raised against a peptide sequence around aa.21~25 (L-G-T-G-G) derived from Human IKK α .

Unconjugated

Primary Antibodies

Apoptosis, Cancer

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

85 kDa

This antibody detects endogenous level of total IKKα protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

CHUK

Conserved helix-loop-helix ubiquitous kinase

Homo sapiens

Yuan ZQ, et al. (2002) J Biol Chem; 277 (33) : 29973-82. Ozes ON, et al. (1999) Nature; 401 (6748) : 82-5.

IKK1, IKKA, IKBKA, TCF16, NFKBIKA, IKK-alpha, H2BFF, I kappa-B kinase alpha, I-kappa-B kinase 1, IKK-A, IKK1

WB, IHC

62241001

Liquid